×

John Lechleiter

Read More

The Unblinding: Has Lilly Solved the Alzheimer’s Puzzle? — An Epilogue

The search continues.

Alzheimer
Read More

The Unblinding: Has Lilly Solved the Alzheimer’s Puzzle?

Statistician Hong Liu-Seifert will emerge from The Cave knowing the outlook for a $90 billion company—what high-level executives are calling a “binary” event that could result in bringing a drug to market by 2018, and windfall profits; or another blow to the field of Alzheimer’s research.

X
X